Long-term Hormone Therapy for Older Women: A New Perspective
Long-term Hormone Therapy for Older Women: Insights from the Menopause Society
The Menopause Society's 2022 Hormone Therapy Position Statement highlights significant findings regarding hormone therapy (HT) for older women. According to the statement, women aged 65 and older can continue using HT with appropriate counseling and risk assessment. This change in perspective reflects an evolving understanding of HT benefits when managed correctly.
Key Recommendations from the Position Statement
- Women over 65 can safely continue hormone therapy.
- Importance of risk assessment before therapy initiation.
- Continued counseling is essential for informed decisions.
Overall, this position statement aims to empower older women in their health choices concerning hormone therapy, emphasizing the crucial role of healthcare providers in this process.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.